Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kristoffer Mads Aaris Henningsen, Susette Krohn Therkelsen, Helle Bruunsgaard, Karen S. Krabbe, Bente Klarlund Pedersen & Jesper Hastrup Svendsen. (2009) Prognostic impact of hs‐CRP and IL‐6 in patients with persistent atrial fibrillation treated with electrical cardioversion. Scandinavian Journal of Clinical and Laboratory Investigation 69:3, pages 425-432.
Read now
Read now
Knut Gjesdal. (2005) Atrial fibrillation: What can we do, what should we do, and what must we do?. Scandinavian Cardiovascular Journal 39:6, pages 324-326.
Read now
Read now
Articles from other publishers (15)
Wilfred Ifeanyi Umeojiako, Maroua Dali, Marissa Lewis, Terrence Chan, Fatuma Nageye, Julie Gladman, Tracy Webb, Tracey Patten, Joanne Glessinger, Rachael Hickford, Savio D'Souza, Fabrizio Cecaro, Winston Martin, Saqib Ghani, Edward Petzer & Peter Kabunga. (2022) Electrical Cardioversion for Persistent Atrial Fibrillation in the Era of Catheter Ablation: A Real-world Observational Study. European Journal of Arrhythmia & Electrophysiology 8:1, pages 25.
Crossref
Crossref
Andrea Natale, Hugh Calkins, Jose Osorio, Scott J. PollakDaniel MelbyFrancis E. Marchlinski, Charles A. AthillCraig Delaughter, Anshul M. Patel, Philip J. GentleskBrian DeVilleLaurent Macle, Kenneth A. Ellenbogen, Srinivas R. Dukkipati, Vivek Y. Reddy & Moussa Mansour. (2021) Positive Clinical Benefit on Patient Care, Quality of Life, and Symptoms After Contact Force–Guided Radiofrequency Ablation in Persistent Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology 14:1.
Crossref
Crossref
Selcuk Kucukseymen & Elif Uygur Kucukseymen. (2017) Atrial Volume Index Is a Predictor in Atrial Fibrillation Relapse. Angiology 68:9, pages 834-834.
Crossref
Crossref
István Baczkó & Peter E. Light. (2015) Resveratrol and derivatives for the treatment of atrial fibrillation. Annals of the New York Academy of Sciences 1348:1, pages 68-74.
Crossref
Crossref
Andres Enriquez, Diego Conde, Wilma Hopman, Ignacio Mondragon, Pablo A. Chiale, Antoni Bay?s de Luna & Adrian Baranchuk. (2014) Advanced Interatrial Block is Associated with Recurrence of Atrial Fibrillation Post Pharmacological Cardioversion. Cardiovascular Therapeutics 32:2, pages 52-56.
Crossref
Crossref
Greg Flaker, Renato D. Lopes, Sana M. Al-Khatib, Antonio G. Hermosillo, Stefan H. Hohnloser, Brian Tinga, Jun Zhu, Puneet Mohan, David Garcia, Jozef Bartunek, Dragos Vinereanu, Steen Husted, Veli Pekka Harjola, Marten Rosenqvist, John H. Alexander & Christopher B. Granger. (2014) Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation. Journal of the American College of Cardiology 63:11, pages 1082-1087.
Crossref
Crossref
Niklas Höglund, Jonas Andersson, Henrik Almroth, Per Tornvall, Anders Englund, Mårten Rosenqvist, Steen M. Jensen & Kurt Boman. (2013) The predictive value of C-reactive protein on recurrence of atrial fibrillation after cardioversion with or without treatment with atorvastatin. International Journal of Cardiology 167:5, pages 2088-2091.
Crossref
Crossref
Ozlem Ozcan Celebi, Savas Celebi, Alper Canbay, Gökhan Ergun, Sinan Aydogdu & Erdem Diker. (2011) The Effect of Sinus Rhythm Restoration on High-Sensitivity C-Reactive Protein Levels and Their Association with Long-Term Atrial Fibrillation Recurrence after Electrical Cardioversion. Cardiology 118:3, pages 168-174.
Crossref
Crossref
A. Arya, J. S. Silberbauer, J. Vrahimides, E. Cheek, A. Mitchell, L. Boodhoo, P. Pugh, J. Large, G. Bordoli, W. Taggu, G. W. Lloyd, N. R. Patel & A. N. Sulke. (2010) First time and repeat cardioversion of atrial tachyarrhythmias - a comparison of outcomes. International Journal of Clinical Practice 64:8, pages 1062-1068.
Crossref
Crossref
Marcello Disertori, Federico Lombardi, Simona Barlera, Roberto Latini, Aldo P. Maggioni, Prisca Zeni, Giuseppe Di Pasquale, Franco Cosmi & Maria Grazia Franzosi. (2010) Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico?Atrial Fibrillation (GISSI-AF) trial. American Heart Journal 159:5, pages 857-863.
Crossref
Crossref
Enrico Vizzardi, Savina Nodari, Gregoriana Zanini, Alessandra Manerba, Silvia Frattini, Alberto Madureri, Riccardo Raddino & Livio Dei Cas. (2009) High sensitivity C-reactive protein: a predictor for recurrence of atrial fibrillation after successful cardioversion. Internal and Emergency Medicine 4:4, pages 309-313.
Crossref
Crossref
Arnljot Tveit, Irene Grundvold, Mona Olufsen, Ingebj?rg Seljeflot, Michael Abdelnoor, Harald Arnesen & Pal Smith. (2007) Candesartan in the prevention of relapsing atrial fibrillation. International Journal of Cardiology 120:1, pages 85-91.
Crossref
Crossref
Peter AndrewAnnibale Sandro Montenero. (2006)
Is
Helicobacter pylori
a cause of atrial fibrillation?
. Future Cardiology 2:4, pages 429-439.
Crossref
Crossref
H. Pleym, O. Tjomsland, A. Asberg, S. Lydersen, A. Wahba, L. Bjella, O. Dale & R. Stenseth. (2005) Effects of autotransfusion of mediastinal shed blood on biochemical markers of myocardial damage in coronary surgery. Acta Anaesthesiologica Scandinavica 49:9, pages 1248-1254.
Crossref
Crossref
Joseph F. Malouf, Ravi Kanagala, Faisal O. Al Atawi, A. Gabriela Rosales, Diane E. Davison, Narayana S. Murali, Teresa S.M. Tsang, Krishnaswamy Chandrasekaran, Naser M. Ammash, Paul A. Friedman & Virend K. Somers. (2005) High Sensitivity C-Reactive Protein. Journal of the American College of Cardiology 46:7, pages 1284-1287.
Crossref
Crossref